| Up
2005P-0079:
DETERMINE WHETHER VIOXX TABLETS, MANUFACTURED BY MERCK HAS BEEN
VOLUNTARILY WITHDRAWN OR WITHHELD FROM SALE FOR SAFETY OR EFFICACY
REASONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 02/22/2005
|
| 02/22/2005
|
| Drug Industry
|
| Teva Pharmaceuticals
USA
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Deborah A. Jaskot
|
|
|
|
|
| ACK1
|
| 02/22/2005
|
| 02/22/2005
|
| Federal
Government
|
| HFA-305
to Teva Pharmaceuticals USA
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Deborah A. Jaskot
|
|
|
| |
Top
| Up
Page last updated
March 8, 2005
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
